Journal of Medical Economics, Volume 22, Issue 4 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 22, Issue 4 (2019)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Volume 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Cardiovascular Medicine

Article
Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients
Gordon Goodall, Mark Lamotte, Mafalda Ramos, Franck Maunoury, Barbora Pejchalova & Gerard de Pouvourville
Pages: 289-296
Published online: 11 Feb 2019
AbstractforCost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients | Full Text | References | PDF (1.6 MB) | EPUB
  • 4406 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
Fingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in Iran
Mehdi Rezaee, Sadegh Izadi, Khosro Keshavarz, Afshin Borhanihaghighi & Ramin Ravangard
Pages: 297-305
Published online: 08 Jan 2019
AbstractforFingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in Iran | Full Text | References | PDF (1.7 MB) | EPUB
  • 1102 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular Medicine

Article
Rivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis
Lisa Aniek de Jong, Judith J. Gout-Zwart, Marina van den Bosch, Mike Koops & Maarten J. Postma
Pages: 306-318
Published online: 15 Jan 2019
AbstractforRivaroxaban for non-valvular atrial fibrillation and venous thromboembolism in the Netherlands: a real-world data based cost-effectiveness analysis | Full Text | References | PDF (2 MB) | EPUB
  • 2312 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access

Respiratory Medicine

Article
Healthcare costs and utilization associated with muscle weakness diagnosis codes in patients with chronic obstructive pulmonary disease: a United States claims analysis
Laurel Trantham, Mirko V. Sikirica, Sean D. Candrilli, Victoria S. Benson, Divya Mohan, David Neil & Ashish V. Joshi
Pages: 319-327
Published online: 11 Jan 2019
AbstractforHealthcare costs and utilization associated with muscle weakness diagnosis codes in patients with chronic obstructive pulmonary disease: a United States claims analysis | Full Text | References | PDF (876.9 KB) | EPUB | Supplemental
  • 789 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Costs of administration, travelling, and productivity losses associated with hospital administration of multiple myeloma drugs in Finland
Petri Mankinen, Ville Vihervaara, Saku Torvinen, Janne Martikainen & Erkki Soini
Pages: 328-335
Published online: 04 Feb 2019
AbstractforCosts of administration, travelling, and productivity losses associated with hospital administration of multiple myeloma drugs in Finland | Full Text | References | PDF (985.9 KB) | EPUB
  • 1425 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes
Xiaoling Cai, Lizheng Shi, Wenjia Yang, Shuyan Gu, Yingyao Chen, Lin Nie & Linong Ji
Pages: 336-343
Published online: 04 Feb 2019
AbstractforCost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 4196 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China
Weiting Liao, Jiaxing Huang, David Hutton & Qiu Li
Pages: 344-349
Published online: 06 Feb 2019
AbstractforCost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China | Full Text | References | PDF (829.1 KB) | EPUB | Supplemental
  • 2881 Views
  • 29 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Article
The economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patients
Ahva Shahabi, Jason Shafrin, Lauren Zhao, Sarah Green, Tammy Curtice, Alexander Marshall & Damemarie Paul
Pages: 350-358
Published online: 12 Feb 2019
AbstractforThe economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patients | Full Text | References | PDF (1 MB) | EPUB
  • 1082 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system
Mary Geitona, Eugena Stamuli, Stylianos Giannakodimos, Vasileios K. Kimiskidis, Vasileios Kountouris, Mata Charokopou & Petros Christou
Pages: 359-364
Published online: 08 Feb 2019
AbstractforLacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system | Full Text | References | PDF (697.6 KB) | EPUB | Supplemental
  • 1422 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Dermatology

Article
Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis
Jashin J. Wu, Corey Pelletier, Brian Ung & Marc Tian
Pages: 365-371
Published online: 04 Feb 2019
AbstractforReal-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis | Full Text | References | PDF (920.8 KB) | EPUB
  • 1772 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Article
The economic burden of depression among adults with rheumatoid arthritis in the United States
Nan Li, Edmond Chan & Steve Peterson
Pages: 372-378
Published online: 05 Feb 2019
AbstractforThe economic burden of depression among adults with rheumatoid arthritis in the United States | Full Text | References | PDF (702.9 KB) | EPUB
  • 2367 Views
  • 27 CrossRef citations
  • 0Altmetric
Free Access

Reproductive Medicine

Letter
RE: A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain
Amir Lass & Stephen Maxwell Montgomery
Pages: 379-380
Published online: 11 Feb 2019
CitationforRE: A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain | Full Text | References | PDF (396.4 KB) | EPUB
  • 623 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Letter
Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain
Salvatore Gizzo, Marcos Ferrando, Monica Lispi, Claudio Ripellino, Nazarena Cataldo & Klaus Bühler
Pages: 381-382
Published online: 13 Feb 2019
CitationforReply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain | Full Text | References | PDF (190 KB) | EPUB
  • 713 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Critical Care

Article
A Monte Carlo simulation estimating US hospital cost reductions associated with hypotension control in septic ICU patients
Eric L. Keuffel, Mitali Stevens, Candace Gunnarsson, John Rizzo, Daniel I. Sessler & Kamal Maheshwari
Pages: 383-389
Published online: 19 Feb 2019
AbstractforA Monte Carlo simulation estimating US hospital cost reductions associated with hypotension control in septic ICU patients | Full Text | References | PDF (736.1 KB) | EPUB | Supplemental
  • 3627 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

Opthalmology

Article
Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada
Vardhaman Patel, Ike Ahmed, Dominik Podbielski, Heather Falvey, Judith Murray & Ron Goeree
Pages: 390-401
Published online: 04 Feb 2019
AbstractforCost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2228 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles